Restauración de la inmunidad innata en pacientes con infección por VIH/SIDA después de inicio de terapia antirretroviral

Background: Highly active antiretroviral therapy (HAART) in HIV/AIDS infection induces an important reduction of the viral load (VL) and an immune system reconstitution. CD4+ T lymphocyte count is the immunological measurement commonly used for the follow up of HIV/AIDS patients. Aim: To study prosp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Afani S,Alejandro, Jiusán L,Lorena, Raby A,Pablo, Sitia,Giovanni, Puente P,Javier, Sepúlveda C,Cecilia, Miranda W,Dante, Cabrera C,Roy, Guidotti,Luca, Lanza,Paola
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2006
Materias:
HIV
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000600003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872006000600003
record_format dspace
spelling oai:scielo:S0034-988720060006000032006-08-14Restauración de la inmunidad innata en pacientes con infección por VIH/SIDA después de inicio de terapia antirretroviralAfani S,AlejandroJiusán L,LorenaRaby A,PabloSitia,GiovanniPuente P,JavierSepúlveda C,CeciliaMiranda W,DanteCabrera C,RoyGuidotti,LucaLanza,Paola Antiretroviral therapy, highly active CD4-positive T-lymphocytes HIV immunity, natural Background: Highly active antiretroviral therapy (HAART) in HIV/AIDS infection induces an important reduction of the viral load (VL) and an immune system reconstitution. CD4+ T lymphocyte count is the immunological measurement commonly used for the follow up of HIV/AIDS patients. Aim: To study prospectively the restoration of the innate immune system in patients with HIV/AIDS infection during their first year on HAART. Patients and Methods: 25 naive HIV/AIDS patients, from San José Hospital and University of Chile Clinical Hospital, Santiago, Chile, were studied between years 2002-2003. Every 4 months after HAART initiation, CD3+, CD4+, CD8+ T lymphocytes and CD16/56+ natural killer (NK) cells were quantified by flow cytometry. NK cell cytotoxicity was measured using radioactive chrome liberation (Cr51). Tumor necrosis factor alpha (TNF-a) and interleukin-10 (IL-10) were measured in peripheral blood mononuclear cells and viral load was determined using Amplicor HIV-1 from Roche Diagnostics Systems. Results: Thirteen of the 25 patients continued in the study. They were all males, average age 35 years old (23-50). At baseline average CD4+ count was 146 cells/µL (31-362) and average viral load was 82.000 copies/mL (4.000-290.000). A raise in CD3+, CD4+, CD8+, and CD16/56 cells was noted at months 9-12 of therapy. Viral load became undetectable in the same period. NK cell function was decreased at the beginning of the therapy (1-4 months), reaching its highest values at months 9-12. There was no significant change in IL-10. TNF-a increased in six patients during the study. Conclusions: In this group of patients, innate immunity was restored during HAART. These results should be confirmed in studies with a longer follow up period and also measuring cytokines such as MIP-1a, MIP-1ß and RANTESinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.134 n.6 20062006-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000600003es10.4067/S0034-98872006000600003
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Antiretroviral therapy, highly active
CD4-positive T-lymphocytes
HIV
immunity, natural
spellingShingle Antiretroviral therapy, highly active
CD4-positive T-lymphocytes
HIV
immunity, natural
Afani S,Alejandro
Jiusán L,Lorena
Raby A,Pablo
Sitia,Giovanni
Puente P,Javier
Sepúlveda C,Cecilia
Miranda W,Dante
Cabrera C,Roy
Guidotti,Luca
Lanza,Paola
Restauración de la inmunidad innata en pacientes con infección por VIH/SIDA después de inicio de terapia antirretroviral
description Background: Highly active antiretroviral therapy (HAART) in HIV/AIDS infection induces an important reduction of the viral load (VL) and an immune system reconstitution. CD4+ T lymphocyte count is the immunological measurement commonly used for the follow up of HIV/AIDS patients. Aim: To study prospectively the restoration of the innate immune system in patients with HIV/AIDS infection during their first year on HAART. Patients and Methods: 25 naive HIV/AIDS patients, from San José Hospital and University of Chile Clinical Hospital, Santiago, Chile, were studied between years 2002-2003. Every 4 months after HAART initiation, CD3+, CD4+, CD8+ T lymphocytes and CD16/56+ natural killer (NK) cells were quantified by flow cytometry. NK cell cytotoxicity was measured using radioactive chrome liberation (Cr51). Tumor necrosis factor alpha (TNF-a) and interleukin-10 (IL-10) were measured in peripheral blood mononuclear cells and viral load was determined using Amplicor HIV-1 from Roche Diagnostics Systems. Results: Thirteen of the 25 patients continued in the study. They were all males, average age 35 years old (23-50). At baseline average CD4+ count was 146 cells/µL (31-362) and average viral load was 82.000 copies/mL (4.000-290.000). A raise in CD3+, CD4+, CD8+, and CD16/56 cells was noted at months 9-12 of therapy. Viral load became undetectable in the same period. NK cell function was decreased at the beginning of the therapy (1-4 months), reaching its highest values at months 9-12. There was no significant change in IL-10. TNF-a increased in six patients during the study. Conclusions: In this group of patients, innate immunity was restored during HAART. These results should be confirmed in studies with a longer follow up period and also measuring cytokines such as MIP-1a, MIP-1ß and RANTES
author Afani S,Alejandro
Jiusán L,Lorena
Raby A,Pablo
Sitia,Giovanni
Puente P,Javier
Sepúlveda C,Cecilia
Miranda W,Dante
Cabrera C,Roy
Guidotti,Luca
Lanza,Paola
author_facet Afani S,Alejandro
Jiusán L,Lorena
Raby A,Pablo
Sitia,Giovanni
Puente P,Javier
Sepúlveda C,Cecilia
Miranda W,Dante
Cabrera C,Roy
Guidotti,Luca
Lanza,Paola
author_sort Afani S,Alejandro
title Restauración de la inmunidad innata en pacientes con infección por VIH/SIDA después de inicio de terapia antirretroviral
title_short Restauración de la inmunidad innata en pacientes con infección por VIH/SIDA después de inicio de terapia antirretroviral
title_full Restauración de la inmunidad innata en pacientes con infección por VIH/SIDA después de inicio de terapia antirretroviral
title_fullStr Restauración de la inmunidad innata en pacientes con infección por VIH/SIDA después de inicio de terapia antirretroviral
title_full_unstemmed Restauración de la inmunidad innata en pacientes con infección por VIH/SIDA después de inicio de terapia antirretroviral
title_sort restauración de la inmunidad innata en pacientes con infección por vih/sida después de inicio de terapia antirretroviral
publisher Sociedad Médica de Santiago
publishDate 2006
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000600003
work_keys_str_mv AT afanisalejandro restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
AT jiusanllorena restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
AT rabyapablo restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
AT sitiagiovanni restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
AT puentepjavier restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
AT sepulvedaccecilia restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
AT mirandawdante restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
AT cabreracroy restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
AT guidottiluca restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
AT lanzapaola restauraciondelainmunidadinnataenpacientesconinfeccionporvihsidadespuesdeiniciodeterapiaantirretroviral
_version_ 1718436264186740736